Sravan K. Emany - 19 Dec 2024 Form 3 Insider Report for Beam Therapeutics Inc. (BEAM)

Role: Chief Financial Officer
Signature: By: /s/ Christine Bellon, Attorney-in-Fact
Issuer symbol: BEAM
Transactions as of: 19 Dec 2024
Transactions value $: $0
Form type: 3
Date filed: 19 Dec 2024, 16:05
Previous filing: 20 Nov 2024
Next filing: 02 Jan 2025
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney